PATENT CLAIM ANALYSIS

Application Number: 16205871
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["424", "133100"]

Abstract:
Methods of treating a patient, such as a patient with breast cancer, and methods of selecting a therapy for a patient. The methods of treating a patient may include determining one or more expression levels for a set of biomarkers from a biological sample of the patient. The biological sample may include breast cancer tissue.

Claim (Index 19):
The method of  claim 16 , wherein the treatment comprises an immunotherapy agent selected from anti-TGF-\u03b21, anti-PD-1, anti-CTLA4, anti-DcR3, anti-IFN-\u03b3*, ex-vivo modulated dendritic cells, or a combination thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 98.0
- Lexical Diversity: 1.81818
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11787044', '13957720', '15019829', '12282029', '13245706']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6722473807908417
- 35 USC 102 Novelty (BERT): 0.5230888543180636
- Combined Prediction Score: 0.6573315281435639
- Mean Citation Score: 211.711128
- Max Citation Score: 224.85518
- Similarity Product: 120.828249354589

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test